Identification of Time-Series Pattern Marker in Its Application to Mortality Analysis of Pneumonia Patients in Intensive Care Unit
Source check: Source checked. Not independent scientific confirmation.
Finding: Historical MIMIC-III EHR time-series study identifies changing mortality-associated markers in ICU pneumonia. Compared LSTM/RNN/GRU and conventional ML; LSTM highest AUROC among sequence models with 10-fold CV and 8:2 split. Exploratory associations, not causal or prospective. This record is limited to the study result and does not establish independent replication or real-world benefit.
Technology: LSTM
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- §§3–5: sequence learning on temporal EHR inputs predicts mortality and temporal-pattern scoring identifies markers.
- Test and result
- Historical MIMIC-III EHR time-series study identifies changing mortality-associated markers in ICU pneumonia. Compared LSTM/RNN/GRU and conventional ML; LSTM highest AUROC among sequence models with 10-fold CV and 8:2 split. Exploratory associations, not causal or prospective.
- Limitation / still unknown
- No prospective clinical benefit or broader external validity is established by the documented study.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.mdpi.com/2075-4426/14/8/812 · https://europepmc.org/article/MED/39202004 · https://www.mdpi.com/2075-4426/14/8/812/notes
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.